Currency: EUR
Period
FY2023 Annual Report
Apr 2, 2024
0.00
-3.43
Strong Buy
May 31, 2024
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Abivax S.A. | 6-K: Report of foreign private issuer (related to financial reporting)
Jun 4 16:56 ET
Abivax S.A. | 20-F: Registration statement / Annual report / Transition report
Apr 5 16:12 ET
Apr 2 10:29 ET
Jan 22 00:00 ET
Read more
Updated: May 31, 2024
Buy
Hold
Sell
No Data